Reuters USA

US FDA expands use of Regeneron’s cholesterol drug in young children

(Reuters) -Regeneron Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol. The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients …

US FDA expands use of Regeneron’s cholesterol drug in young children Read More »

Mexican national pleads guilty in California crash that killed 13 migrants

(Reuters) – A Mexican national has pleaded guilty to federal charges of organizing a human-smuggling operation that led to the deaths of 13 Mexican and Guatemalan migrants in a highway crash near the border in Southern California two years ago. Jose Cruz Noguez, 49, a legal permanent U.S. resident from Mexicali, Mexico, entered his plea …

Mexican national pleads guilty in California crash that killed 13 migrants Read More »

As Fed meeting looms, economists see central bank balance sheet in new light

By Michael S. Derby WASHINGTON (Reuters) – Historic Federal Reserve lending to banks in the wake of Silicon Valley Bank’s collapse punched a huge hole in its effort to shrink the size of its balance sheet, though economists don’t view that turnaround as a shift back toward a stimulative use of its asset stockpile. Instead, …

As Fed meeting looms, economists see central bank balance sheet in new light Read More »

German ‘wise ones’ see inflation uptick if banking woes halt rate rises

BERLIN (Reuters) -Germany’s economic council on Wednesday warned that inflation could remain high for longer or even pick up again if financial market worries prevent central banks from raising interest rates. “The recent increase in financial market risks has made it more difficult for central banks to fight inflation,” the five “wise ones” who advise …

German ‘wise ones’ see inflation uptick if banking woes halt rate rises Read More »